The deliberate mischaracterization of the typical late stage Lyme patient suggests to me that some people know. To be sure, not many. But someone is dragging the collective medical communities' feet on direct testing, and that orchestration has to be for a reason that extends well beyond either...
Too late for a large swath of the late stage Lyme community, which received that broad brush stroke characterization by a former senior NIH peep (I think), back like 12 years or so ago. :)
Edit to add: Just as there are those within the ME/CFS community who question the extent of the NIH and...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.